Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review - 16/02/16
Abstract |
The treatment paradigm for nonmelanoma skin cancer remains surgical. This fact combined with its remarkably high incidence positions it as the fifth most costly cancer to treat in the Medicare population. To address this, consideration of alternative medical therapeutics is warranted. Intralesional 5-fluorouracil is a potentially affordable option that may demand further investigation. This literature review examines current data on its efficacy and adverse effects.
Le texte complet de cet article est disponible en PDF.Key words : basal cell carcinoma, 5-fluorouracil, intralesional, management, medical therapy, nonmelanoma skin cancer, squamous cell carcinoma
Abbreviations used : BCC, FU, NMSC, SCC
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
Vol 74 - N° 3
P. 552-557 - mars 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?